Advarra

Columbia, United States Founded: 2017 • Age: 9 yrs Acquired By Blackstone
Global research compliance services including IRB and consulting are provided.

About Advarra

Advarra is a Healthcare company based in Columbia (United States) founded in 2017, and was acquired by Blackstone in June 2022. Global research compliance services including IRB and consulting are provided. It operates in the Healthcare and Business Services sectors. The company has 249 employees. Advarra has completed 6 acquisitions, including Bio-Optronics, Forte Research and IntegReview IRB. Its chief executive, as recorded, is Pat Donnelly. Its website advarra.com draws about 102 thousand monthly visits. Its Indian entity Advarra India Private Limited reported revenue of ₹62.58 Cr. Advarra offers products and services including IRB Review, Clinical Conductor, and OnCore. Its focus areas include Management Consulting Services, Horizontal, HealthTech and Life Sciences Tech. Its competitors include Teneo, ZS and Prophet; 2 of its 3 listed competitors have raised funding.

Company details

Advarra was founded in 2017 and is headquartered in Columbia, United States. Regulatory compliance services for global research are offered, encompassing IRB, IBC, consulting, and research technology solutions. Operations focus on institutional review processes, with the company serving as the largest integrated provider of IRB services across more than 3,200 health systems, cancer centers, academic medical centers, and investigators worldwide.

  • Headquarters Columbia, United States
  • Employees 249
  • Stage Acquired
  • Sectors
    Healthcare
    Business Services
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website advarra.com
  • Social LinkedIn X
  • Acquired by Blackstone (Jun 2022)
  • Legal Name Advarra India Private Limited
  • Date of Incorporation 03 Nov, 2010
  • Jurisdiction Bengaluru, Karnataka, India
Key Metrics
  • Indian entity revenue
    ₹62.58 Cr

    FY 2025 · +55% YoY

  • Indian entity net profit
    ₹5.86 Cr

    FY 2025 · 9% margin

  • Indian entity EBITDA
    ₹11.53 Cr

    FY 2025 · 18% margin

  • Investors
    Blackstone

    & 2 more

  • Employee Count
    249
  • Investments & Acquisitions
  • Acquired by
    Blackstone

    & 1 more

    (Jun 2022)

Products & Services of Advarra

Advarra offers a comprehensive portfolio of products and services, including IRB Review, Clinical Conductor, and OnCore.

IRB Review
Ethics Review

Service for overseeing institutional review boards in clinical trials

Clinical Conductor
Trial Management

Software platform for managing clinical trial operations

OnCore
Data Management

System for handling clinical research data and workflows

Investors in Advarra

Advarra has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Blackstone, CPP Investments and Genstar Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Diversified investment management is provided across multiple asset classes.
1985blackstone.comNew York, United States
gencap.com
Pension fund assets are managed for sustainable long-term growth.
1997cppinvestments.comToronto, Canada
Premium access

Investor details for Advarra

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Advarra India Private Limited (Advarra)

Advarra India Private Limited is the primary company behind Advarra. The board of Advarra India Private Limited currently have 5 directors; the longest-serving is Orla Elizabeth Mester, appointed in 2017. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Orla Elizabeth Mester
DIN 08016955
Director13 Dec 20178 yrs 10 moAdvarra India Private Limited
Vinaykumar Venkatachalapathi Nama
DIN 08087724
Whole-time director11 May 20188 yrs 6 moAdvarra India Private Limited
Scott Edward Uebele
DIN 10597595
Director08 May 20242 yrs 6 moAdvarra India Private Limited
Swetha Raju
DIN 10692573
Whole-time director13 Sep 20242 yrs 1 moAdvarra India Private Limited
Marco Vincent Capasso
DIN 08621820
Director19 May 20251 yr 5 moAdvarra India Private Limited

People of Advarra

183 people are tracked at Advarra (79 in leadership, 104 in team); the tracked headcount is 249.

NameRoleGroup
Pat Donnelly
CEOLeadership
Gadi Saarony
CEOLeadership
Scott Hoffman
Chief Commercial OfficerLeadership
Jay Westfall
DirectorLeadership
Dwight Van Inwegen
CFOLeadership
Chief Legal & Risk Officer & Secretary to the BoardLeadership
Alek Bituin
Vice President, Sales Execution & StrategyLeadership
Natalie Powell Hellmer
Director, Technology Programs PMOLeadership
Ajay Indrajit
Senior Director Global Support ServicesLeadership
Jennifer Monaco
Associate Director, Contracts And ProposalsLeadership
Tim McCormick
VP Of EngineeringLeadership
Lauri Carlile
Chief Research Services OfficerLeadership
COOLeadership
Brian Hart
Chief Technology OfficerLeadership
Julie Neil
Director, Partner ProgramLeadership
Sneha Shettar
Associate DirectorLeadership
Esmond Kane
Chief Information Security OfficerLeadership
Gene James
Vice President, Business SystemsLeadership
Brad Cottreau
Senior Vice President Of Global Enterprise SalesLeadership
Anthony Colavito III
Services Engagement DirectorLeadership

163 more people are available in the full profile.

Premium access

Complete people profiles for Advarra

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Advarra

Figures of Advarra India Private Limited, the primary company behind Advarra, for FY 2025. Revenue was ₹62.58 Cr (+55% year on year). Net profit was ₹5.86 Cr (9% margin). EBITDA was ₹11.53 Cr (18% margin). Revenue has grown at a compounded annual rate of +50% over three years and +37% over five years.

  • ₹62.58 CrRevenue · FY 2025 · +55% YoY
  • ₹5.86 CrNet profit · 9% margin
  • ₹11.53 CrEBITDA · 18% margin
  • ₹1 LakhPaid-up capital
  • 249Employees (provident fund records)
  • +50%Revenue CAGR, 3 years
  • +37%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Advarra India Private Limited are on its company page.

Premium access

Detailed financial statements for Advarra

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Advarra

Advarra has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Bio-Optronics, Forte Research and IntegReview IRB.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Clinical trial management systems are provided for healthcare workflow optimization.
bio-optronics.comRochester, United States1985Mar 2021••••
Consulting services to the life science and consumer goods industries
yourencore.comIndianapolis, United States2003Dec 2020••••
Clinical trial platfoms for sites as well as patients
longboat.comDublin, Ireland2014Nov 2020••••
Clinical research services are provided to the biopharma sector.
integreview.comAustin, United States1999Nov 2020••••
Specialized software for clinical research compliance and efficiency is developed.
forteresearch.comMadison, United States2000Sep 2019••••
Provider of clinical research site training, quality & regulatory consulting, and review services
quorumreview.comSeattle, United States1992Mar 2019••••
Premium access

Complete acquisition details for Advarra

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Advarra

9 dated milestones of Advarra across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Advarra is founded.
  2. Acquisition Acquires Quorum Review.
  3. Exit Acquired by Genstar Capital.
  4. Acquisition Acquires Forte Research.
  5. Acquisition Acquires IntegReview IRB.
  6. Acquisition Acquires Longboat.
  7. Acquisition Acquires YourEncore.
  8. Acquisition Acquires Bio-Optronics.
  9. Exit Acquired by Blackstone.

Competitors of Advarra

Advarra has 3 listed competitors in our database, 2 of them funded. They include Teneo, ZS and Prophet.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
teneo.com2011New York, United States$400M313
Business consulting, financial advisory, and crisis management services are provided.
zs.com1983Evanston, United States
Strategic and management consulting services are provided worldwide.
prophet.com1992San Francisco, United States$94.33M
Brand and marketing consulting solutions provider
Premium access

Detailed competitors of Advarra

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Advarra

The website of Advarra (advarra.com) receives about 102.4K visits a month and ranks #325,515 among all websites worldwide, #267 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    102.4K

    ▼ 1.7% vs previous month

  • Unique visitors
    27.1K

    per month

  • Global rank
    #325,515

    among all websites

  • Category rank
    #267

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Advarra. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cirbi.net
cirbi.net
100%
#187,438–
clinicalleader.com
60%
680.7K#948,222View details
thefdagroup.com
56%
64.2K#641,651View details
florencehc.com
56%
28.6K#961,319View details
medrio.com
56%
133.1K#199,158View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 23 similar websites and full traffic analytics for Advarra

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 23 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Advarra (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Advarra

Premium access

Complete news archive for Advarra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Advarra

Advarra was founded in 2017.

Advarra is headquartered in Columbia, United States.

Pat Donnelly is the CEO of Advarra, as recorded in our data.

Advarra has 249 employees.

The primary company behind Advarra, Advarra India Private Limited, reported revenue of ₹62.58 Cr for FY 2025, up 55% year on year.

Advarra was founded in 2017 and is headquartered in Columbia, United States. Regulatory compliance services for global research are offered, encompassing IRB, IBC, consulting, and research technology solutions. Operations focus on institutional review processes, with the company serving as the largest integrated provider of IRB services across more than 3,200 health systems, cancer centers, academic medical centers, and investigators worldwide.

Advarra's top competitors include ZS, Teneo and Prophet.

Advarra offers IRB Review, Clinical Conductor, and OnCore.

Advarra has made 6 acquisitions, including Bio-Optronics, Forte Research, and IntegReview IRB.

Advarra has 3 investors. Key investors include Blackstone, CPP Investments, and Genstar Capital.

Advarra operates through Advarra India Private Limited.

Yes. Advarra was acquired by Blackstone in June 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available